Xcelerate Inc. (XCRT) Fair Value 2026

XCRT · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.2 /10

32 fundamental signals · 1 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-27, Xcelerate Inc. (XCRT) trades at $0.01. QOC: 3.2/10. Value Trap Risk: 0/100 (SAFE). 1/13 models active.

Key Facts

Ticker
XCRT
Price
$0.01
Quality Score
3.2/10
Value Trap Risk
0/100
Models Active
1/13
Last Updated
Strength: PWERM suggests +8.6% upside with 4% confidence
Risk: Below-average Quality Score of 3.2/10 signals weak fundamentals

What Fair Value Does Each Model Give XCRT?

1 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Low Conviction
 $0.01 +8.6%

All Models Active

All 1 models are displayed above.

What Is Xcelerate Inc. (XCRT) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, the weight of evidence tilts decidedly bullish for Xcelerate Inc.. Trading at $0.01 against an estimated intrinsic value of $0.01, 1 of 1 active models flag meaningful upside of +8.6% at the median.

What Do the Models Say About XCRT?

1 of 13 models are currently active for XCRT. All 1 active models suggest the stock trades below fair value. See which stocks rank higher →

How Does XCRT Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, XCRT ranks #59 by Quality of Company score. CirclFi's QOC score of 3.2/10 evaluates 32 fundamental signals. A score of 3.2 signals below-average fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

Xcelerate Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is XCRT a Value Trap?

CirclFi's Value Trap algorithm assigns XCRT a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Xcelerate Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Xcelerate Inc. is rated at 3.2/10. This weak-tier score exhibits fundamental weaknesses that warrant careful scrutiny.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every XCRT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across XCRT's 1 active models, average confidence is 4%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Xcelerate Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

9 related Medical Care Facilities stocks with 13-model coverage

FCHSFirst Choice Healthcare Solutions, Inc.QOC 3.6NIVFNewGenIvf Group LimitedQOC 2.1GMRSGMR Solutions Inc.QOC 3.8ADUSAddus HomeCare CorporationQOC 8.9PARKPark Dental Partners, Inc.QOC 3.9NHCNational HealthCare CorporationQOC 8.7MDPediatrix Medical Group, Inc.QOC 7.9INNVInnovAge Holding Corp.QOC 6.7CDIXCardiff Lexington CorporationQOC 5.7

Read investment analysis: FCHS · NIVF · GMRS · ADUS · PARK · NHC · MD · INNV · CDIX

Which Other Stocks Have a Similar Quality Score to XCRT?

7 companies across all industries closest to XCRT’s Quality of Company score of 3.2/10.

SIMOSilicon Motion Technology CorporationQOC 3.2FWFWFlywheel Advanced Technology, Inc.QOC 3.2DSGXThe Descartes Systems Group Inc.QOC 3.2QGENQiagen N.V.QOC 3.2TUTHStandard Dental Labs Inc.QOC 3.2AMSSAMASS Brands, Inc.QOC 3.2NVDANVIDIA CorporationQOC 10.0

Read investment analysis: SIMO · FWFW · DSGX · QGEN · TUTH · AMSS · NVDA

Where Does XCRT Sit in CirclFi's Medical Care Facilities Rankings?

XCRT is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About Xcelerate Inc.’s Valuation?

What is Xcelerate Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Xcelerate Inc. (XCRT). The Quality of Company score is 3.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is XCRT overvalued or undervalued right now?

At $0.01, 1 of 1 active models suggest XCRT may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Xcelerate Inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 3.2 mean for XCRT?

Xcelerate Inc.'s QOC of 3.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on XCRT?

CirclFi analyzes XCRT with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is XCRT a value trap in 2026?

Xcelerate Inc.'s Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Xcelerate Inc. (XCRT) a Quality of Company score of 3.2/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/XCRT/ · Methodology
Primary sources for this XCRT valuation
  • Financial statements: Xcelerate Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001138586) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for XCRT as of ; valuations recomputed .